Exploring the combined therapeutic efficacy of bexarotene and icariin in type 2 diabetic rats.

Icariin treatment exhibited robust antidiabetic effects with fewer side effects than other treatment options in this study. In future studies, long-term and varying doses of icariin will contribute to the development of novel antidiabetic drugs.